InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the complete record of transactions filed by Kalofonos Isabel, Directeur Commercial. Director active across 1 company, notably Crinetics Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been recorded. Activity tracked since 5 January 2026. The latest transaction was disclosed on 23 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Kalofonos Isabel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
34,000 shares0Common StockSEC:0001628280-26-011715:0
2,500 shares@ US$40.590.0019% mcap50.0% of flowCommon StockSEC:0001628280-26-001230:0
2 of 2 declarations
About Kalofonos Isabel
Isabel Kalofonos serves as Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. She is responsible for the company's commercial strategy and business development. Isabel brings expertise in sales management and business strategy, enabling her to drive growth initiatives. Her role is essential for achieving Crinetics' performance objectives.
